FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007303905> ?p ?o ?g. }

• W2007303905 endingPage "238" @default.
• W2007303905 startingPage "231" @default.
• W2007303905 abstract "Aims: To evaluate the expression of the intermediate filament desmin in reactive mesothelium and malignant mesothelioma and to compare its utility with five other previously reported immunomarkers claimed to be of use in distinguishing reactive from neoplastic mesothelium. Methods and results: Sixty cases of malignant pleural mesothelioma and 40 cases of reactive mesothelial hyperplasia formed the study group. Cases were immunohistochemically stained with desmin, epithelial membrane antigen (EMA), p53, Bcl‐2, P‐glycoprotein and platelet‐derived growth factor receptor (PDGF‐R) β‐chain by the avidin–biotin complex method. The cohort of malignant pleural mesotheliomas were immunoreactive to desmin, EMA and p53 in 6/60 (10%), 48/60 (80%) and 27/60 (45%), respectively. In comparison, the cohort of reactive mesothelial hyperplasias were immunoreactive to desmin, EMA and p53 in 34/40 (85%), 8/40 (20%) and 0/40 (0%), respectively. In a smaller cohort ( n = 15) of malignant pleural mesotheliomas, Bcl‐2, P‐glycoprotein and PDGF‐R β‐chain were expressed in 0/15 (0%), 2/15 (13%) and 15/15 (100%), respectively. In a small cohort ( n = 15) of reactive mesothelial hyperplasias, Bcl‐2, P‐glycoprotein and PDGF‐R β‐chain were immunoreactive in 0/15 (0%), 0/15 (0%) and 6/15 (40%), respectively. Conclusions: Desmin and EMA appear to be the most useful markers in distinguishing benign from malignant mesothelial proliferations. Desmin appears to be preferentially expressed in reactive mesothelium and EMA appears to be preferentially expressed in neoplastic mesothelium. The complementary use of both markers is advocated in ascertaining the nature of mesothelial proliferations. Immunohistochemical detection of mutated p53 oncoprotein appeared to be of less utility in this study on account of the low marker sensitivity for malignant mesothelioma. However, p53 antibody may be of use as a second‐line marker of neoplastic mesothelium within a standard immunohistochemical panel of antibodies. In this study, Bcl‐2, P‐glycoprotein and PDGF‐R β‐chain appear to be of no use in distinguishing reactive from neoplastic mesothelium, although more formal evaluation of these markers is required." @default.
• W2007303905 created "2016-06-24" @default.
• W2007303905 creator A5032156853 @default.
• W2007303905 creator A5062069675 @default.
• W2007303905 creator A5080058390 @default.
• W2007303905 date "2003-08-27" @default.
• W2007303905 modified "2023-10-15" @default.
• W2007303905 title "The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2" @default.
• W2007303905 cites W166494923 @default.
• W2007303905 cites W1968312126 @default.
• W2007303905 cites W1970019219 @default.
• W2007303905 cites W1971037765 @default.
• W2007303905 cites W1972206827 @default.
• W2007303905 cites W1972741795 @default.
• W2007303905 cites W2010867812 @default.
• W2007303905 cites W2014395565 @default.
• W2007303905 cites W2023749097 @default.
• W2007303905 cites W2034616956 @default.
• W2007303905 cites W2038184877 @default.
• W2007303905 cites W2044175197 @default.
• W2007303905 cites W2050782914 @default.
• W2007303905 cites W2050935896 @default.
• W2007303905 cites W2061660794 @default.
• W2007303905 cites W2065322239 @default.
• W2007303905 cites W2077840200 @default.
• W2007303905 cites W2081311764 @default.
• W2007303905 cites W2089316398 @default.
• W2007303905 cites W2141695030 @default.
• W2007303905 cites W2146642286 @default.
• W2007303905 cites W2146691593 @default.
• W2007303905 cites W2148954987 @default.
• W2007303905 cites W2185082678 @default.
• W2007303905 cites W4242404509 @default.
• W2007303905 cites W69391523 @default.
• W2007303905 doi "https://doi.org/10.1046/j.1365-2559.2003.01686.x" @default.
• W2007303905 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12940775" @default.
• W2007303905 hasPublicationYear "2003" @default.
• W2007303905 type Work @default.
• W2007303905 sameAs 2007303905 @default.
• W2007303905 citedByCount "195" @default.
• W2007303905 countsByYear W20073039052012 @default.
• W2007303905 countsByYear W20073039052013 @default.
• W2007303905 countsByYear W20073039052014 @default.
• W2007303905 countsByYear W20073039052015 @default.
• W2007303905 countsByYear W20073039052016 @default.
• W2007303905 countsByYear W20073039052017 @default.
• W2007303905 countsByYear W20073039052018 @default.
• W2007303905 countsByYear W20073039052019 @default.
• W2007303905 countsByYear W20073039052020 @default.
• W2007303905 countsByYear W20073039052021 @default.
• W2007303905 countsByYear W20073039052022 @default.
• W2007303905 countsByYear W20073039052023 @default.
• W2007303905 crossrefType "journal-article" @default.
• W2007303905 hasAuthorship W2007303905A5032156853 @default.
• W2007303905 hasAuthorship W2007303905A5062069675 @default.
• W2007303905 hasAuthorship W2007303905A5080058390 @default.
• W2007303905 hasConcept C142724271 @default.
• W2007303905 hasConcept C147447768 @default.
• W2007303905 hasConcept C204232928 @default.
• W2007303905 hasConcept C2777407522 @default.
• W2007303905 hasConcept C2779072444 @default.
• W2007303905 hasConcept C2779747549 @default.
• W2007303905 hasConcept C2909640154 @default.
• W2007303905 hasConcept C71924100 @default.
• W2007303905 hasConcept C86803240 @default.
• W2007303905 hasConceptScore W2007303905C142724271 @default.
• W2007303905 hasConceptScore W2007303905C147447768 @default.
• W2007303905 hasConceptScore W2007303905C204232928 @default.
• W2007303905 hasConceptScore W2007303905C2777407522 @default.
• W2007303905 hasConceptScore W2007303905C2779072444 @default.
• W2007303905 hasConceptScore W2007303905C2779747549 @default.
• W2007303905 hasConceptScore W2007303905C2909640154 @default.
• W2007303905 hasConceptScore W2007303905C71924100 @default.
• W2007303905 hasConceptScore W2007303905C86803240 @default.
• W2007303905 hasIssue "3" @default.
• W2007303905 hasLocation W20073039051 @default.
• W2007303905 hasLocation W20073039052 @default.
• W2007303905 hasOpenAccess W2007303905 @default.
• W2007303905 hasPrimaryLocation W20073039051 @default.
• W2007303905 hasRelatedWork W1967371888 @default.
• W2007303905 hasRelatedWork W2041683934 @default.
• W2007303905 hasRelatedWork W2066660928 @default.
• W2007303905 hasRelatedWork W2181855412 @default.
• W2007303905 hasRelatedWork W2292416779 @default.
• W2007303905 hasRelatedWork W2393701990 @default.
• W2007303905 hasRelatedWork W2416789845 @default.
• W2007303905 hasRelatedWork W2525683625 @default.
• W2007303905 hasRelatedWork W4300934514 @default.
• W2007303905 hasRelatedWork W4312418556 @default.
• W2007303905 hasVolume "43" @default.
• W2007303905 isParatext "false" @default.
• W2007303905 isRetracted "false" @default.
• W2007303905 magId "2007303905" @default.
• W2007303905 workType "article" @default.